MX2015012346A - Derivados de pirazolilbenzo[d]imidazol. - Google Patents

Derivados de pirazolilbenzo[d]imidazol.

Info

Publication number
MX2015012346A
MX2015012346A MX2015012346A MX2015012346A MX2015012346A MX 2015012346 A MX2015012346 A MX 2015012346A MX 2015012346 A MX2015012346 A MX 2015012346A MX 2015012346 A MX2015012346 A MX 2015012346A MX 2015012346 A MX2015012346 A MX 2015012346A
Authority
MX
Mexico
Prior art keywords
absent
alkyl
attached
nr2r3
pyrazole
Prior art date
Application number
MX2015012346A
Other languages
English (en)
Other versions
MX364172B (es
Inventor
Daria Zdzalik
Joanna Lipner
Maciej Wieczorek
Karolina Dzwonek
Abdellah Yamani
Krzysztof Dubiel
Monika Lamparska-Przybysz
Paulina Grygielewicz
Aleksandra Stanczak
Original Assignee
Celon Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celon Pharma Sa filed Critical Celon Pharma Sa
Publication of MX2015012346A publication Critical patent/MX2015012346A/es
Publication of MX364172B publication Critical patent/MX364172B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un compuesto representado por la Fórmula general (I), en donde los átomos de hidrógeno mostrados como unidos a anillos pirazol y benzimidazol están unidos a uno de los átomos de nitrógeno del anillo pirazol o benzimidazol, respectivamente; R1 representa -X-Q-P, en donde X está ausente o representa -CH2-, -C(O)-, o -C(O)NH-(CH2)k-, en donde k es 0,1 o 2; Q se selecciona del grupo que consiste de Q1, Q2, Q3, Q4 y Q5; P está ausente o representa alquilo de C1-C3 de cadena recta o ramificada, -(CH2)l-NR2R3, o -(CH2)m-C(O)NR2R3, en donde I y m representan independientemente uno del otro 0, 1 o 2, con la condición de que cuando B en Q1 representa un átomo de oxígeno, entonces P está ausente; y R2 y R3 representan independientemente alquilo de C1 o C2, o R2 y R3 junto con el átomo de nitrógeno al cual ambos están unidos forman un anillo heterocíclico saturado de 6 miembros, en donde uno de los átomos de carbono se puede reemplazar con oxígeno, -NH- o -N(C1-C2)alquilo-; y sales de adición ácidas del mismo. El compuesto puede ser útil en el tratamiento de enfermedades del cáncer. (ver Fórmula).
MX2015012346A 2013-03-14 2014-03-07 Derivados de pirazolilbenzo[d]imidazol. MX364172B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL403149A PL403149A1 (pl) 2013-03-14 2013-03-14 Nowe związki pochodne pirazolilobenzo[d]imidazolu
PCT/IB2014/059515 WO2014141015A1 (en) 2013-03-14 2014-03-07 Pyrazolylbenzo[d]imidazole derivatives

Publications (2)

Publication Number Publication Date
MX2015012346A true MX2015012346A (es) 2016-02-03
MX364172B MX364172B (es) 2019-04-15

Family

ID=50382512

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015012346A MX364172B (es) 2013-03-14 2014-03-07 Derivados de pirazolilbenzo[d]imidazol.

Country Status (20)

Country Link
US (1) US9776988B2 (es)
EP (1) EP2970210B1 (es)
JP (1) JP6594779B2 (es)
KR (1) KR102266546B1 (es)
CN (1) CN105008348B (es)
AU (1) AU2014229401B2 (es)
BR (1) BR112015023092B1 (es)
CA (1) CA2900629C (es)
DK (1) DK2970210T3 (es)
EA (1) EA026782B1 (es)
ES (1) ES2622376T3 (es)
HR (1) HRP20170190T1 (es)
HU (1) HUE031368T2 (es)
IL (1) IL241234A0 (es)
MX (1) MX364172B (es)
PL (2) PL403149A1 (es)
PT (1) PT2970210T (es)
SI (1) SI2970210T1 (es)
WO (1) WO2014141015A1 (es)
ZA (1) ZA201507548B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3296297A1 (en) * 2016-09-15 2018-03-21 Centre National De La Recherche Scientifique Benzimidazol derivatives for treating filovirus infection
CN107698538B (zh) * 2016-11-30 2020-02-14 内蒙古京东药业有限公司 罗沙替丁醋酸酯盐酸盐的中间体3-(1-哌啶甲基)苯酚的制备方法
CN107163030B (zh) * 2017-06-20 2020-03-24 河南工业大学 具有吡唑母核的小分子杂环化合物及其用于制备抗菌、抗肿瘤药物的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1200433B1 (en) 1999-08-02 2006-03-22 Ortho-McNeil Pharmaceutical, Inc. C-6 RING-SUBSTITUTED PYRIDO[1,2-a]BENZIMIDAZOLE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS
US6897208B2 (en) 2001-10-26 2005-05-24 Aventis Pharmaceuticals Inc. Benzimidazoles
FR2831536A1 (fr) * 2001-10-26 2003-05-02 Aventis Pharma Sa Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
WO2006033943A2 (en) * 2004-09-17 2006-03-30 Exelixis, Inc Pyrazole kinase modulators and methods of use
AU2005321091B2 (en) 2004-12-30 2012-04-12 Astex Therapeutics Limited Pyrazole compounds that modulate the activity of CDK, GSK and Aurora kinases
EP1968579A1 (en) * 2005-12-30 2008-09-17 Astex Therapeutics Limited Pharmaceutical compounds
US7737149B2 (en) * 2006-12-21 2010-06-15 Astrazeneca Ab N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
MX2010014234A (es) * 2008-06-19 2011-03-25 Astrazeneca Ab Compuestos pirazol 436.
EP2649062B1 (en) * 2010-11-30 2015-04-08 Takeda Pharmaceutical Company Limited Bicyclic compounds as inhibitors of acetyl-coa carboxylase (acc)
LT2707385T (lt) * 2011-05-13 2017-12-11 Glaxosmithkline Biologicals Sa Iš anksto sulieti rsv f antigenai

Also Published As

Publication number Publication date
BR112015023092B1 (pt) 2021-11-16
KR102266546B1 (ko) 2021-06-21
CA2900629A1 (en) 2014-09-18
PL2970210T3 (pl) 2017-09-29
JP2016516024A (ja) 2016-06-02
US20160039794A1 (en) 2016-02-11
AU2014229401A1 (en) 2015-08-20
MX364172B (es) 2019-04-15
WO2014141015A1 (en) 2014-09-18
EA026782B1 (ru) 2017-05-31
SI2970210T1 (sl) 2017-05-31
KR20150126893A (ko) 2015-11-13
EA201591617A1 (ru) 2016-01-29
BR112015023092A2 (pt) 2017-07-18
ZA201507548B (en) 2017-02-22
CN105008348B (zh) 2018-07-10
PT2970210T (pt) 2017-04-07
CN105008348A (zh) 2015-10-28
ES2622376T3 (es) 2017-07-06
HUE031368T2 (en) 2017-07-28
DK2970210T3 (en) 2017-04-10
US9776988B2 (en) 2017-10-03
AU2014229401B2 (en) 2018-05-17
PL403149A1 (pl) 2014-09-15
EP2970210A1 (en) 2016-01-20
HRP20170190T1 (hr) 2017-04-07
EP2970210B1 (en) 2017-01-04
JP6594779B2 (ja) 2019-10-23
CA2900629C (en) 2020-12-15
IL241234A0 (en) 2015-11-30

Similar Documents

Publication Publication Date Title
PH12016500147B1 (en) Plant disease control composition and its use
PH12014501719A1 (en) Pyridone derivatives
PH12016500146B1 (en) Plant disease control composition and its use
CY1123533T1 (el) Ν-αλκυλαρυλο-5-οξυαρυλο-οκταϋδρο-κυκλοπεντα [c] πυρρολια ως αρνητικοι αλλοστερικοι ρυθμιστες των nr2b
PH12016500148A1 (en) Plant disease control composition and its use
IN2014MN01897A (es)
PH12015502232A1 (en) Naphthyridine derivatives useful as alpha-v-beta-6 integrin antagonists
MY177250A (en) Novel nicotinamide derivative or salt thereof
UA109013C2 (en) INDOLISIN DERIVATIVES
EA201100763A1 (ru) Методы получения хинолиновых производных
MX367897B (es) Derivados de piridazinona macrociclicos.
MX348917B (es) Proceso para la producción de estetrol.
NZ710052A (en) Novel pyrazol derivatives
PH12015501813A1 (en) Monocyclic pyridine derivative
MX2021006404A (es) Derivados de piridona policiclica sustituida y profarmaco de los mismos.
EA201591105A1 (ru) ПИРИМИДО[4,5-b]ХИНОЛИН-4,5-(3H,10H)-ДИОНЫ В КАЧЕСТВЕ СУПРЕССОРОВ НОНСЕНС МУТАЦИЙ
PH12016500480B1 (en) Antibacterial 2h-indazole derivatives
MX2016005993A (es) Anfifilos biscationicos y triscationicos como agentes antimicrobianos.
PH12015502429A1 (en) Dicarboxylic acid compound
MX2016002718A (es) Derivados de ceto-imidazopiridina como moduladores del receptor huerfano relacionado con receptor retinoide (porc).
MX2015012346A (es) Derivados de pirazolilbenzo[d]imidazol.
MX2015002705A (es) Compuestos de piridinona para usarse en terapia fotodinamica.
MA32342B1 (fr) Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MX358151B (es) Derivado de sitaxentan.
MX2016000057A (es) Derivados organometalicos de 2-ciano-2-aminobenzoato-propilo y su uso como antihelminticos.

Legal Events

Date Code Title Description
FG Grant or registration